Technologies for continuous glucose monitoring: Current problems and future promises

Journal of Diabetes Science and Technology

Volumn 4, Issue 6, 2010, Pages 1540-1562

  Vaddiraju, Santhisagar ^a   Burgess, Diane J ^a   Tomazos, Ioannis ^a   Jain, Faquir C ^b   Papadimitrakopoulos, Fotios ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b University of Connecticut   (United States)

Author keywords

Accuracy; Calibration; Continuous glucose monitoring; Glucose detection; Glucose sensors; Invasiveness

Indexed keywords

BIOLOGICAL MARKER;

AMBULATORY MONITORING; BLOOD; DIABETES MELLITUS; ELECTRONICS; EQUIPMENT DESIGN; FORECASTING; GLUCOSE BLOOD LEVEL; HUMAN; INSTRUMENTATION; INSULIN INFUSION; METABOLISM; METHODOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; REVIEW; SIGNAL PROCESSING; TIME;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS; EQUIPMENT DESIGN; FORECASTING; HUMANS; INSULIN INFUSION SYSTEMS; MINIATURIZATION; MONITORING, AMBULATORY; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SIGNAL PROCESSING, COMPUTER-ASSISTED; TIME FACTORS;

EID: 79952995519     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400632     Document Type: Article

References (189)

1. American Diabetes Association. Diabetes statistics. http://www.diabetes. org/diabetes-basics/diabetes- statistics/. Accessed September 28, 2010.
2. International Diabetes Federation. IDF diabetes atlas. Data. http://www.diabetesatlas.org/content/regional- data. Accessed September 28, 2010.
3. World Health Organization. Diabetes fact sheet. http://www.who.int/ mediacentre/factsheets/fs312/en/index.html.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.
5. American Diabetes Association. Clinical practice recommendations 1997. Diabetes Care. 1997;20 Suppl 1:S1-70.
6. Reach G, Wilson GS. Can continuous glucose monitoring be used for the treatment of diabetes. Anal Chem. 1992;64(6):381A-386A.
7. The Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. JAMA. 1996;276(17):1409-15.
8. Newman JD, Turner AP. Home blood glucose biosensors: a commercial perspective. Biosens Bioelectron. 2005;20(12):2435-53.
9. Vaddiraju S, Burgess DJ, Jain FC, Papadimitrakopoulos F. The role of H2O2 outer diffusion on the performance of implantable glucose sensors. Biosens Bioelectron. 2009;24(6):1557-62.
10. Vaddiraju S, Singh H, Burgess DJ, Jain FC, Papadimitrakopoulos F. Enhanced glucose sensor linearity using poly(vinyl alcohol) hydrogels. J Diabetes Sci Technol. 2009;3(4):863-74.
11. Degani Y, Heller A. Direct electrical communication between chemically modified enzymes and metal electrodes. I. Electron transfer from glucose oxidase to metal electrodes via electron relays, bound covalently to the enzyme. J Phys Chem. 1987;91(6):1285-9.
12. Pishko MV, Katakis I, Lindquist SE, Ye L, Gregg BA, Heller A. Direct electrical communication between graphite electrodes and surface adsorbed glucose oxidase/redox polymer complexes. Angewandte Chemie Internat Ed. 1990;29(1):82-4.
13. Dong S, Wang B, Liu B. Amperometric glucose sensor with ferrocene as an electron transfer mediator. Biosens Bioelectron. 1992;7(3):215-22.
14. Palys B, Bokun A, Rogalski J. Poly-o-phenylenediamine as redox mediator for laccase', Electrochim Acta. 2007;52(24):7075-82.
15. Yu X, Sotzing GA, Papadimitrakopoulos F, Rusling JF. Wiring of enzymes to electrodes by ultrathin conductive polyion underlayers: enhanced catalytic response to hydrogen peroxide. Anal Chem. 2003;75(17):4565-71.
16. Joshi PP, Merchant SA, Wang Y, Schmidtke DW. Amperometric biosensors based on redox polymer-carbon nanotube-enzyme composites. Anal Chem. 2005;77(10):3183-8.
17. Vaddiraju S, Tomazos I, Burgess DJ, Jain FC, Papadimitrakopoulos F. Emerging synergy between nanotechnology and implantable biosensors: a review. Biosens Bioelectron. 2010;25(7):1553-65.
18. Wang J. Glucose biosensors: 40 years of advances and challenges. Electroanalysis. 2001;13:983-8.
19. Malinauskas A, Kuzmarskytė J, Meškys R, Ramanavièius A. Bioelectrochemical sensor based on PQQ-dependent glucose dehydrogenase', Sens Actuators B. 2004;100:387-94.
20. Blaedel WJ, Jenkins RA. Study of a reagentless lactate electrode. Anal Chem. 1976;48(8):1240-7.
21. Newman JD, Turner AP. Home blood glucose biosensors: a commercial perspective. Biosens Bioelectron. 2005;20(12):2435-53.
22. Skoog M, Johansson G. Internal supply of coenzyme to an amperometric glucose biosensor based on a chemically modified electrode. Biosens Bioelectron. 1991;6(5):407-12.
23. Gorton L, Bremle G, Csöregi E, Jönsson-Pettersson G, Persson B. Amperometric glucose sensors based on immobilized glucose-oxidizing enzymes and chemically modified electrodes. Anal Chim Acta. 1991;249(1):43-54.
24. Mizutani F, Yabuki S, Katsura T. Amperometric enzyme electrode with the use of dehydrogenase and NAD(P)H oxidase. Sens Actuator B. 1993;13-14:574-5.
25. Laurinavièius V, Kurtinaitienė B, Liauksminas V, Ramanavicius A, Meškys R, Rudomanskis R. Oxygen insensitive glucose biosensor based on PQQ-dependent glucose dehydrogenase. Anal Lett. 1999;32(2):299-316.
26. Habermuller K, Ramanavièius A, Laurinavièius V, Schuhmann W. An oxygen-insensitive reagentless glucose biosensor based on Osmium-complex modified polypyrrole. Electroanal. 2000;12(17):1383-9.
27. Loew N, Scheller FW, Wollenberger U. Characterization of self-assembling of glucose dehydrogenase in mono- and multilayers on gold electrodes. Electroanal. 2004;16(13-14):1149-54.
28. Yamazaki T, Kojima K, Sode K. Extended-range glucose sensor employing engineered glucose dehydrogenases. Anal Chem. 2000;72(19):4689-93.
29. Yuan JH, Wang K, Xia XH. Highly ordered platinum-nanotubule arrays for amperometric glucose sensing. Adv Funct Mater. 2005;15(5):803-9.
30. Wang J, Thomas DF, Chen A. Nonenzymatic electrochemical glucose sensor based on nanoporous PtPb networks. Anal Chem. 2008 Feb 15;80(4):997-1004.
31. Zhou YG, Yang S, Qian QY, Xia XH. Gold nanoparticles integrated in a nanotube array for electrochemical detection of glucose. Electrochem Commun. 2009;11(1):216-9.
32. Myung Y, Jang DM, Cho YJ, Kim HS, Park J. Nonenzymatic amperometric glucose sensing of platinum, copper sulfide, and tin oxide nanoparticle-carbon nanotube hybrid nanostructures. J Phys Chem C. 2009;113(4):1251-9.
33. Tura A, Maran A, Pacini G. Non-invasive glucose monitoring: assessment of technologies and devices according to quantitative criteria. Diabetes Res Clin Pract. 2007;77(1):16-40.
34. Oliver NS, Toumazou C, Cass AE, Johnston DG. Glucose sensors: a review of current and emerging technology. Diabet Med. 2009;26(3):197-210.
35. Pickup JC, Hussain F, Evans ND, Rolinski OJ, Birch DJ. Fluorescence-based glucose sensors. Biosens Bioelectron. 2005;20(12):2555-65.
36. Moschou EA, Sharma BV, Deo SK, Daunert S. Fluorescence glucose detection: advances toward the ideal in vivo biosensor. J Fluoresc. 2004;14(5):535-47.
37. Mansouri S, Schultz JS. A miniature optical glucose sensor based on affinity binding. Biotechnol. 1984;2:885-90.
38. Meadows D, Schultz JS. Fiber-optic biosensors based on fluorescence energy transfer. Talanta. 1988;35(2):145-50.
39. Russell RJ, Pishko MV, Gefrides CC, McShane MJ, Coté GL. A fluorescence-based glucose biosensor using concanavalin A and dextran encapsulated in a poly(ethylene glycol) hydrogel. Anal Chem. 1999;71(15):3126-32.
40. Barone PW, Strano MS. Reversible control of carbon nanotube aggregation for a glucose affinity sensor. Angew Chem Int Ed Engl. 2006;45(48):8138-41.
41. Barone PW, Parker RS, Strano MS. In vivo fluorescence detection of glucose using a single-walled carbon nanotube optical sensor: design, fluorophore properties, advantages, and disadvantages. Anal Chem. 2005;77(23):7556-62.
42. Liang F, Pan T, Sevick-Muraca EM. Measurements of fluorescence resonance energy transfer in the concanavalin A-dextran affinity system using frequency-domain lifetime spectroscopy. Proc SPIE. 2005;5702:7-14.
43. Khalil OS. Non-invasive glucose measurement technologies: an update from 1999 to the dawn of the new millennium. Diabetes Technol Ther. 2004;6(5):660-97.
44. Domschke A, March WF, Kabilan S, Lowe C. Initial clinical testing of a holographic non-invasive contact lens glucose sensor. Diabetes Technol Ther. 2006;8(1):89-93.
45. Badugu R, Lakowicz JR, Geddes CD. A glucose-sensing contact lens: from bench top to patient. Curr Opin Biotechnol. 2005;16(1):100-7.
46. Larin KV, Eledrisi MS, Motamedi M, Esenaliev RO. Noninvasive blood glucose monitoring with optical coherence tomography: a pilot study in human subjects. Diabetes Care. 2002;25(12):2263-7.
47. Helwig AM, Arnold MA, Small GW. Evaluation of Kromoscopy: resolution of glucose and urea. Appl Opt. 2000;39(25):4715-20.
48. Rabinovitch B, March WF, Adams RL. Noninvasive glucose monitoring of the aqueous humor of the eye: Part I. Measurement of very small optical rotations. Diabetes Care. 1982;5(3):254-8.
49. Rawer R, Stork W, Müller-Glaser KD. Polarimetric methods for measurement of intra ocular glucose concentration. Biomed Tech (Berl). 2002;47 Suppl 1 Pt 1:186-8.
50. Malchoff CD, Shoukri K, Landau JI, Buchert JM. A novel noninvasive blood glucose monitor. Diabetes Care. 2002;25(12):2268-75.
51. Weiss R, Yegorchikov Y, Shusterman A, Raz I. Noninvasive continuous glucose monitoring using photoacoustic technology-results from the first 62 subjects. Diabetes Technol Ther. 2007;9(1):68-74.
52. MacKenzie HA, Ashton HS, Spiers S, Shen Y, Freeborn SS, Hannigan J, Lindberg J, Rae P. Advances in photoacoustic noninvasive glucose testing. Clin Chem. 1999;45(9):1587-95.
53. Enejder AM, Scecina TG, Oh J, Hunter M, Shih WC, Sasic S, Horowitz GL, Feld MS. Raman spectroscopy for noninvasive glucose measurements. J Biomed Opt. 2005;10(3):031114.
54. Lyandres O, Yuen JM, Shah NC, VanDuyne RP, Walsh JT, Glucksberg MR. Progress toward an in vivo surface-enhanced Raman spectroscopy glucose sensor. Diabetes Technol Ther. 2008;10(4):257-65.
55. Alexeev VL, Das S, Finegold DN, Asher SA. Photonic crystal glucose-sensing material for noninvasive monitoring of glucose in tear fluid. Clin Chem. 2004;50(12):2353-60.
56. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med. 1999;106(4):399-403.
57. Amaral CE, Wolf B. Effects of glucose in blood and skin impedance spectroscopy. Presented at: IEEE AFRICON 2007, Windhoek/Namibia, September 25-28, 2007: 1-7.
58. Huber D, Talary M, Dewarrat F, Caduff A. The compensation of perturbing temperature fluctuation in glucose monitoring technologies based on impedance spectroscopy. Med Biol Eng Comput. 2007;45(9):863-76.
59. Caduff A, Dewarrat F, Talary M, Stalder G, Heinemann L, Feldman Y. Non-invasive glucose monitoring in patients with diabetes: a novel system based on impedance spectroscopy. Biosens Bioelectron. 2006;22(5):598-604.
60. Pfützner A, Caduff A, Larbig M, Schrepfer T, Forst T. Impact of posture and fixation technique on impedance spectroscopy used for continuous and noninvasive glucose monitoring. Diabetes Technol Ther. 2004;6(4):435-41.
61. Wentholt IM, Hoekstra JB, Zwart A, DeVries JH. Pendra goes Dutch: lessons for the CE mark in Europe. Diabetologia. 2005;48(6):1055-8.
62. Gourzi M, Rouane A, Guelaz R, Nadi M, Jaspard F. Study of a new electromagnetic sensor for glycaemia measurement: in vitro results on blood pig. J Med Eng Technol. 2003 Nov-Dec;27(6):276-81.
63. Gourzi M, Rouane A, Guelaz R, Alavi MS, McHugh MB, Nadi M, Roth P. Non-invasive glycaemia blood measurements by electromagnetic sensor: study in static and dynamic blood circulation. J Med Eng Technol. 2005;29(1):22-6.
64. Renard E. Implantable continuous glucose sensors. Curr Diabetes Rev. 2008 Aug;4(3):169-74.
65. Lutgers HL, Hullegie LM, Hoogenberg K, Sluiter WJ, Dullaart RP, Wientjes KJ, Schoonen AJ. Microdialysis measurement of glucose in subcutaneous adipose tissue up to three weeks in type 1 diabetic patients. Neth J Med. 2000;57(1):7-12.
66. Klaus S, Heringlake M, Bahlmann L. Bench-to-bedside review: Microdialysis in intensive care medicine. Crit Care. 2004;8(5):363-8.
67. Klonoff DC. Microdialysis of interstitial fluid for continuous glucose measurement. Diabetes Technol Ther. 2003;5(4):539-43.
68. Mastrototaro JJ, Johnson KW, Morff RJ, Lipson D, Andrew CC, Allen DJ. An electroenzymatic glucose sensor fabricated on a flexible substrate. Sens Actuators B Chem. 1991;5(1):139-44.
69. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care. 2006;29(1):44-50.
70. Liao KC, Hogen-Esch T, Richmond FJ, Marcu L, Clifton W, Loeb GE. Percutaneous fiber-optic sensor for chronic glucose monitoring in vivo. Biosens Bioelectron. 2008;23(10):1458-65.
71. Rao G, Glikfeld P, Guy RH. Reverse iontophoresis: development of a noninvasive approach for glucose monitoring. Pharm Res. 1993;10(12):1751-5.
72. Rhee SY, Chon S, Koh G, Paeng JR, Oh S, Woo JT, Kim SW, Kim JW, Kim YS. Clinical experience of an iontophoresis based glucose measuring system. J Korean Med Sci. 2007;22(1):70-3.
73. Gebhart S, Faupel M, Fowler R, Kapsner C, Lincoln D, McGee V, Pasqua J, Steed L, Wangsness M, Xu F, Vanstory M. Glucose sensing in transdermal body fluid collected under continuous vacuum pressure via micropores in the stratum corneum. Diabetes Technol Ther. 2003;5(2):159-66.
74. Mitragotri S, Coleman M, Kost J, Langer R. Analysis of ultrasonically extracted interstitial fluid as a predictor of blood glucose levels. J Appl Physiol. 2000;89(3):961-6.
75. Park EJ, Werner J, Beebe J, Chan S, Smith NB. Noninvasive ultrasonic glucose sensing with large pigs (approximately 200 pounds) using a lightweight cymbal transducer array and biosensors. J Diabetes Sci Technol. 2009;3(3):517-23.
76. Kiistala U. Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol. 1968;50(2):129-37.
77. Robert JJ. Continuous monitoring of blood glucose. Horm Res. 2002;57 Suppl 1:81-4.
78. Khalil OS. Spectroscopic and clinical aspects of noninvasive glucose measurements. Clin Chem. 1999;45(2):165-77.
79. De Block C, Vertommen J, Manuel-y-Keenoy B, Van Gaal L. Minimally-invasive and non-invasive continuous glucose monitoring systems: indications, advantages, limitations and clinical aspects. Curr Diabetes Rev. 2008 Aug;4(3):159-68.
80. Ferrante do Amaral CE, Wolf B. Current development in non-invasive glucose monitoring. Med Eng Phys. 2008;30(5):541-9.
81. International Organization for Standardization. In vitro diagnostic test systems: requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. ISO 15197:2003.
82. Clarke WL, Kovatchev B. Continuous glucose sensors: continuing questions about clinical accuracy. J Diabetes Sci Technol. 2007;1(5):669-75.
83. Klonoff D, Bernhardt P, Ginsberg BH, Joseph J, Mastrototaro J, Parker DR, Vesper H, Vigersky R, Clinical and Laboratory Standards Institute. Performance metrics for continuous interstitial glucose monitoring; approved guideline. CLSI document POCT05-A, 2008.
84. D'Archangelo MJ. New guideline supports the development and evaluation of continuous interstitial glucose monitoring devices. J Diabetes Sci Technol. 2008;2(2):332-4.
85. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307-10.
86. Kovatchev BP, Gonder-Frederick LA, Cox DJ, Clarke WL. Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care. 2004;27(8):1922-8.
87. Cox DJ, Clarke WL, Gonder-Frederick L, Pohl S, Hoover C, Snyder A, Zimbelman L, Carter WR, Bobbitt S, Pennebaker J. Accuracy of perceiving blood glucose in IDDM. Diabetes Care. 1985;8(6):529-36.
88. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care. 1987;10(5):622-8.
89. Cameron BD, Anumula H. Development of a real-time corneal birefringence compensated glucose sensing polarimeter. Diabetes Technol Ther. 2006;8(2):156-64.
90. Tierney MJ, Tamada JA, Potts RO, Jovanovic L, Garg S, Cygnus Research Team. Clinical evaluation of the GlucoWatch biographer: a continual, non-invasive glucose monitor for patients with diabetes. Biosens Bioelectron. 2001;16(9-12):621-9.
91. Diabetes Research in Children Network (DirecNet) Study Group. Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: experience of the Diabetes Research in Children Network. Diabetes Care. 2004;27(3):722-6.
92. Kost J, Mitragotri S, Gabbay RA, Pishko M, Langer R. Transdermal monitoring of glucose and other analytes using ultrasound. Nat Med. 2000;6(3):347-50.
93. Sachedina N, Pickup JC. Performance assessment of the Medtronic-MiniMed Continuous Glucose Monitoring System and its use for measurement of glycaemic control in type 1 diabetic subjects. Diabet Med. 2003 Dec;20(12):1012-5.
94. Weinstein RL, Schwartz SL, Brazg RL, Bugler JR, Peyser TA, McGarraugh GV. Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements. Diabetes Care. 2007;30(5):1125-30.
95. Renard E, Shah R, Miller M, Kolopp M, Costalat G, Bringer J. Sustained safety and accuracy of central IV glucose sensors connected to implanted insulin pumps and short-term closed-loop trials in diabetic patients. Diabetologia 2003;46:A47.
96. Rossetti P, Porcellati F, Fanelli CG, Bolli GB. Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycemia, its recovery, and post-hypoglycemic hyperglycemia in humans. Diabetes Technol Ther. 2006 Jun;8(3):326-37.
97. Nielsen JK, Freckmann G, Kapitza C, Ocvirk G, Koelker KH, Kamecke U, Gillen R, Amann-Zalan I, Jendrike N, Christiansen JS, Koschinsky T, Heinemann L. Glucose monitoring by microdialysis: performance in a multicentre study. Diabet Med. 2009;26(7):714-21.
98. Gourzi M, Rouane A, Guelaz R, Alavi MS, McHugh MB, Nadi M, Roth P. Non-invasive glycaemia blood measurements by electromagnetic sensor: study in static and dynamic blood circulation. J Med Eng Technol. 2005;29(1):22-6.
99. Parkes JL, Slatin SL, Pardo S, Ginsberg BH. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care. 2000;23(8):1143-8.
100. Lodwig V, Heinemann L, Glucose Monitoring Study Group. Continuous glucose monitoring with glucose sensors: calibration and assessment criteria. Diabetes Technol Ther. 2003;5(4):572-86.
101. Onuki Y, Bhardwaj U, Papadimitrakopoulos F, Burgess DJ. A review of the biocompatibity of implantable devices: current challenges to overcome foreign body response. J Diabetes Sci Technol. 2008;2(6):1003-15.
102. Heller A. Implanted electrochemical glucose sensors for the management of diabetes. Annu Rev Biomed Eng. 1999;1:153-75.
103. Wentholt IM, Hart AA, Hoekstra JB, Devries JH. Relationship between interstitial and blood glucose in type 1 diabetes patients: delay and the push-pull phenomenon revisited. Diabetes Technol Ther. 2007;9(2):169-75.
104. Hovorka R, Shojaee-Moradie F, Carroll PV, Chassin LJ, Gowrie IJ, Jackson NC, Tudor RS, Umpleby AM, Jones RH. Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. Am J Physiol Endocrinol Metab. 2002;282(5):E992-1007.
105. Boyne MS, Silver DM, Kaplan J, Saudek CD. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes. 2003;52(11):2790-4.
106. Kulcu E, Tamada JA, Reach G, Potts RO, Lesho MJ. Physiological differences between interstitial glucose and blood glucose measured in human subjects. Diabetes Care. 2003;26(8):2405-9.
107. Tipnis R, Vaddiraju S, Jain F, Burgess DJ, Papadimitrakopoulos F. Layer-by-layer assembled semipermeable membrane for amperometric glucose sensors. J Diabetes Sci Technol. 2007;1(2):193-200.
108. Wilson GS, Gifford R. Biosensors for real-time in vivo measurements. Biosens Bioelectron. 2005;20(12):2388-403.
109. Cembrowski GC, Smith B, O'Malley EM. Increases in whole blood glucose measurements using optically based self-monitoring of blood glucose analyzers due to extreme canadian winters. J Diabetes Sci Technol. 2009;3(4):661-7.
110. Schoemaker M, Andreis E, Röper J, Kotulla R, Lodwig V, Obermaier K, Stephan P, Reuschling W, Rutschmann M, Schwaninger R, Wittmann U, Rinne H, Kontschieder H, Strohmeier W. The SCGM1 System: subcutaneous continuous glucose monitoring based on microdialysis technique. Diabetes Technol Ther. 2003;5(4):599-608.
111. Harman-Boehm I, Gal A, Raykhman AM, Naidis E, Mayzel Y. Noninvasive glucose monitoring: increasing accuracy by combination of multi-technology and multi-sensors. J Diabetes Sci Technol. 2010;4(3):583-95.
112. Castle JR, Ward WK. Amperometric glucose sensors: sources of error and potential benefit of redundancy. J Diabetes Sci Technol. 2010;4(1):221-5.
113. Vaddiraju S, Tomazos I, Burgess DJ, Jain FC, Papadimitrakopoulos F. Emerging synergy between nanotechnology and implantable biosensors: a review. Biosens Bioelectron. 2010;25(7):1553-65.
114. Wang J. In vivo glucose monitoring: towards 'Sense and Act' feedback-loop individualized medical systems. Talanta. 2008;75(3):636-41.
115. Burmeister JJ, Gerhardt GA. Self-referencing ceramic-based multisite microelectrodes for the detection and elimination of interferences from the measurement of L-glutamate and other analytes. Anal Chem. 2001;73(5):1037-42.
116. Jeong RA, Hwang JY, Joo S, Chung TD, Park S, Kang SK, Lee WY, Kim HC. In vivo calibration of the subcutaneous amperometric glucose sensors using a non-enzyme electrode. Biosens Bioelectron. 2003;19(4):313-9.
117. O'Brien KB, Killoran SJ, O'Neill RD, Lowry JP. Development and characterization in vitro of a catalase-based biosensor for hydrogen peroxide monitoring. Biosens Bioelectron. 2007;22(12):2994-3000.
118. O'Neill RD. Microvoltammetric techniques and sensors for monitoring neurochemical dynamics in vivo: a review. Analyst. 1994;119(5):767-79.
119. Dong S, Wang B, Liu B. Amperometric glucose sensor with ferrocene as an electron transfer mediator. Biosens Bioelectron. 1992;7(3):215-22.
120. Kim SN, Rusling JF, Papadimitrakopoulos F. Carbon nanotubes for electronic and electrochemical detection of biomolecules. Adv Mater. 2007;19(20):3214-28.
121. Yu X, Sotzing GA, Papadimitrakopoulos F, Rusling JF. Wiring of enzymes to electrodes by ultrathin conductive polyion underlayers: enhanced catalytic response to hydrogen peroxide. Anal Chem. 2003;75(17):4565-71.
122. Yuhashi N, Tomiyama M, Okuda J, Igarashi S, Ikebukuro K, Sode K. Development of a novel glucose enzyme fuel cell system employing protein engineered PQQ glucose dehydrogenase. Biosens Bioelectron. 2005;20(10):2145-50.
123. Kay CW, Mennenga B, Görisch H, Bittl R. Structure of the pyrroloquinoline quinone radical in quinoprotein ethanol dehydrogenase. J Biol Chem. 2006;281(3):1470-6.
124. McNichols RJ, Coté GL. Optical glucose sensing in biological fluids: an overview. J Biomed Opt. 2000;5(1):5-16.
125. Barone PW, Strano MS. Single walled carbon nanotubes as reporters for the optical detection of glucose. J Diabetes Sci Technol. 2009;3(2):242-52.
126. Armour JC, Lucisano JY, McKean BD, Gough DA. Application of chronic intravascular blood glucose sensor in dogs. Diabetes. 1990;39(12):1519-26.
127. Updike SJ, Shults MC, Rhodes RK, Gilligan BJ, Luebow JO, von Heimburg D. Enzymatic glucose sensors. Improved long-term performance in vitro and in vivo. ASAIO J. 1994;40(2):157-63.
128. Gilligan BJ, Shults MC, Rhodes RK, Updike SJ. Evaluation of a subcutaneous glucose sensor out to 3 months in a dog model. Diabetes Care. 1994;17(8):882-7.
129. Gerritsen M, Jansen JA, Lutterman JA. Performance of subcutaneously implanted glucose sensors for continuous monitoring. Neth J Med. 1999;54(4):167-79.
130. Kerner W. Implantable glucose sensors: present status and future developments. Exp Clin Endocrinol Diabetes. 2001;109 Suppl 2:S341-6.
131. Koschinsky T, Heinemann L. Sensors for glucose monitoring: technical and clinical aspects. Diabetes Metab Res Rev. 2001;17(2):113-23.
132. Shichiri M, Kawamori R, Yamasaki Y. [Use of a wearable artificial pancreas]. Nippon Rinsho. 1985;43(12):2629-34.
133. Shichiri M, Kawamori R, Yamasaki Y, Hakui N, Abe H. Wearable artificial endocrine pancreas with needle-type glucose sensor. Lancet. 1982;2(8308):1129- 31.
134. Kvist PH, Iburg T, Aalbaek B, Gerstenberg M, Schoier C, Kaastrup P, Buch-Rasmussen T, Hasselager E, Jensen HE. Biocompatibility of an enzyme-based, electrochemical glucose sensor for short-term implantation in the subcutis. Diabetes Technol Ther. 2006;8(5):546-59.
135. Harrison DJ, Turner RF, Baltes HP. Characterization of perfluoro-sulfonic acid polymer coated enzyme electrodes and a miniaturized integrated potentiostat for glucose analysis in whole blood. Anal Chem. 1988;60(19):2002-7.
136. Moussy F, Harrison DJ, O'Brien DW, Rajotte RV. Performance of subcutaneously implanted needle-type glucose sensors employing a novel trilayer coating. Anal Chem. 1993;65(15):2072-7.
137. Galeska I, Chattopadhyay D, Moussy F, Papadimitrakopoulos F. Calcification-resistant Nafion/Fe3+ assemblies for implantable biosensors. Biomacromolecules. 2000;1(2):202-7.
138. Galeska I, Chattopadhyay D, Papadimitrakopoulos F. Application of polyanion/Fe3 multilayered membranes in prevention of biosensor mineralization. J Macromol Sci Pure Appl Chem. 2002;39(10):1207-22.
139. Praveen SS, Hanumantha R, Belovich JM, Davis BL. Novel hyaluronic acid coating for potential use in glucose sensor design. Diabetes Technol Ther. 2003;5(3):393-9.
140. Galeska I, Hickey T, Moussy F, Kreutzer D, Papadimitrakopoulos F. Characterization and biocompatibility studies of novel humic acids based films as membrane material for an implantable glucose sensor. Biomacromolecules. 2001;2(4):1249-55.
141. Ward WK, Slobodzian EP, Tiekotter KL, Wood MD. The effect of microgeometry, implant thickness and polyurethane chemistry on the foreign body response to subcutaneous implants. Biomaterials. 2002;23(21):4185-92.
142. Bhardwaj U, Sura R, Papadimitrakopoulos F, Burgess DJ. Controlling acute inflammation with fast releasing dexamethasone-PLGA microsphere/PVA hydrogel composites for implantable devices. J Diabetes Sci Technol. 2007;1(1):8-17.
143. Patil SD, Papadmitrakopoulos F, Burgess DJ. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Control Release. 2007;117(1):68-79.
144. Yang Y, Zhang SF, Kingston MA, Jones G, Wright G, Spencer SA. Glucose sensor with improved haemocompatibilty. Biosens Bioelectron. 2000;15(5-6):221-7.
145. Ishihara K, Nakabayashi N, Nishida K, Sakakida M, Shichiri M. New biocompatible polymer: application for implantable glucose sensor. Diagnost Biosens Polymer. 1994;556:194-210.
146. Ishihara K, Tanaka S, Furukawa N, Kurita K, Nakabayashi N. Improved blood compatibility of segmented polyurethanes by polymeric additives having phospholipid polar groups. I. Molecular design of polymeric additives and their functions. J Biomed Mater Res. 1996;32(3):391-9.
147. Suri JT, Cordes DB, Cappuccio FE, Wessling RA, Singaram B. Continuous glucose sensing with a fluorescent thin-film hydrogel. Angew Chem Int Ed Engl. 2003;42(47):5857-9.
148. Hickey T, Kreutzer D, Burgess DJ, Moussy F. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. J Biomed Mater Res. 2002;61(2):180-7.
149. Hickey T, Kreutzer D, Burgess DJ, Moussy F. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials. 2002;23(7):1649-56.
150. Norton LW, Koschwanez HE, Wisniewski NA, Klitzman B, Reichert WM. Vascular endothelial growth factor and dexamethasone release from nonfouling sensor coatings affect the foreign body response. J Biomed Mater Res A. 2007;81(4):858-69.
151. Frost M, Meyerhoff ME. In vivo chemical sensors: tackling biocompatibility. Anal Chem. 2006;78(21):7370-7.
152. Frost MC, Batchelor MM, Lee Y, Zhang H, Kang Y, Oh BK, Wilson GS, Gifford R, Rudich SM, Meyerhoff ME. Preparation and characterization of implantable sensors with nitric oxide release coatings. Microchem J. 2003;74:277-88.
153. Frost MC, Meyerhoff ME. Fabrication and in vivo evaluation of nitric oxide-releasing electrochemical oxygen-sensing catheters. Methods Enzymol. 2004;381:704-15.
154. Sung, WJ; Na, K; Bae, YH,' Biocompatibility and interference eliminating property of pullulan acetate/polyethylene glycol/heparin membrane for the outer layer of an amperometric glucose sensor. Sens Actuators B Chem. 2004;99(2-3):393-8.
155. Kim TK, Burgess DJ. Pharmacokinetic characterization of 14C-vascular endothelial growth factor controlled release microspheres using a rat model. J Pharm Pharmacol. 2002;54(7):897-905.
156. Brauker JH, Carr-Brendel VE, Martinson LA, Crudele J, Johnston WD, Johnson RC. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res. 1995;29(12):1517-24.
157. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. J Biomed Mater Res. 1997;37(3):401-12.
158. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. J Biomed Mater Res. 1998;40(4):598-605.
159. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. J Biomed Mater Res. 1998;40(4):586-97.
160. Popat KC, Eltgroth M, Latempa TJ, Grimes CA, Desai TA. Decreased Staphylococcus epidermis adhesion and increased osteoblast functionality on antibiotic-loaded titania nanotubes. Biomaterials. 2007;28(32):4880-8.
161. Sahlin H, Contreras R, Gaskill DF, Bjursten LM, Frangos JA. Anti-inflammatory properties of micropatterned titanium coatings. J Biomed Mater Res A. 2006;77(1):43-9.
162. Lopez CA, Fleischman AJ, Roy S, Desai TA. Evaluation of silicon nanoporous membranes and ECM-based microenvironments on neurosecretory cells. Biomaterials. 2006;27(16):3075-83.
163. Striemer CC, Gaborski TR, McGrath JL, Fauchet PM. Charge- and size-based separation of macromolecules using ultrathin silicon membranes. Nature. 2007;445(7129):749-53.
164. Desai TA, Hansford DJ, Leoni L, Essenpreis M, Ferrari M. Nanoporous anti-fouling silicon membranes for biosensor applications. Biosens Bioelectron. 2000;15(9-10):453-62.
165. Sharma S, Desai TA. Nanostructured antifouling poly(ethylene glycol) films for silicon-based microsystems. J Nanosci Nanotechnol. 2005;5(2):235-43.
166. Narayan RJ, Aggarwal R, Wei W, Jin C, Monteiro-Riviere NA, Crombez R, Shen W. Mechanical and biological properties of nanoporous carbon membranes. Biomed Mater. 2008;3(3):034107.
167. Saha K, Pollock JF, Schaffer DV, Healy KE. Designing synthetic materials to control stem cell phenotype. Curr Opin Chem Biol. 2007;11(4):381-7.
168. House JL, Anderson EM, Ward WK. Immobilization techniques to avoid enzyme loss from oxidase-based biosensors: a one-year study. J Diabetes Sci Technol. 2007;1(1):18-27.
169. McMahon CP, Killoran SJ, O'Neill RD. Design variations of a polymer-enzyme composite biosensor for glucose: Enhanced analyte sensitivity without increased oxygen dependence. J Electroanal Chem. 2005;580(2):193-202.
170. Updike SJ, Shults MC, Rhodes RK, Gilligan BJ, Luebow JO, von Heimburg D. Enzymatic glucose sensors: improved long-term performance in vitro and in vivo. ASAIO J. 1994;40(2):157-63.
171. Binyamin G, Chen T, Heller A. Sources of instability of 'wired' enzyme anodes in serum: Urate and transition metal ions. J Electroanal Chem. 2001;500(1-2):604-11.
172. Yu B, Moussy Y, Moussy F. Coil-type implantable glucose biosensor with excess enzyme loading. Front Biosci. 2005;10:512-20.
173. Kim J, Grate JW, Wang P. Nanostructures for enzyme stabilization. Chem Eng Sci. 2006;61(3):1017-26
174. Guto PM, Kumar CV, Rusling JF. Thermostable peroxidase-polylysine films for biocatalysis at 90 degrees C. J Phys Chem B. 2007;111(30):9125-31.
175. Wang ZG, Wan LS, Liu ZM, Huang XJ, Xu ZK. Enzyme immobilization on electrospun polymer nanofibers: an overview. J Mol Catal B-Enzym. 2009;56(4):189-95.
176. Phadtare S, Vinod VP, Wadgaonkar PP, Rao M, Sastry M. Free-standing nanogold membranes as scaffolds for enzyme immobilization. Langmuir. 2004;20(9):3717-23.
177. Chen T, Barton SC, Binyamin G, Gao Z, Zhang Y, Kim HH, Heller A. A miniature biofuel cell. J Am Chem Soc. 2001;123(35):8630-1.
178. Mano N, Mao F, Heller A. Characteristics of a miniature compartment-less glucose-O2 biofuel cell and its operation in a living plant. J Am Chem Soc. 2003 May 28;125(21):6588-94.
179. Mano N, Mao F, Heller A. A miniature biofuel cell operating in a physiological buffer. J Am Chem Soc. 2002;124(44):12962-3.
180. Ward WK, House JL, Birck J, Anderson EM, Jansen LB. A wire-based dual-analyte sensor for glucose and lactate: in vitro and in vivo evaluation. Diabetes Technol Ther. 2004;6(3):389-401.
181. McMahon CP, O'Neill RD. Polymer-enzyme composite biosensor with high glutamate sensitivity and low oxygen dependence. Anal Chem. 2005;77(4):1196-9.
182. Crespi F. In vivo voltammetric detection of neuropeptides with micro carbon fiber biosensors: Possible selective detection of somatostatin. Anal Biochem. 1991;194(1):69-76.
183. Tamiya E, Sugiura Y, Takeuchi T, Suzuki M, Karube I, Akiyama A. Ultra micro glutamate sensor using platinized carbon-fiber electrode and integrated counter electrode. Sens Actuators B Chem. 1993;10(3):179-84.
184. Wu Z, Chen L, Shen G, Yu R. Platinum nanoparticle-modified carbon fiber ultramicroelectrodes for mediator-free biosensing. Sens Actuators B Chem. 2006;119(1):295-301.
185. Errachid A, Ivorra A, Aguiló J, Villa R, Zine N, Bausells J. New technology for multi-sensor silicon needles for biomedical applications. Sens Actuators B Chem. 2001;78(1-2):279-84.
186. Johnson KW, Mastrototaro JJ, Howey DC, Brunelle RL, Burden-Brady PL, Bryan NA, Andrew CC, Rowe HM, Allen DJ, Noffke BW, McMahan WC, Morff RJ, Lipson D, Nevin RS. In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissue. Biosens Bioelectron. 1992;7(10):709-14.
187. Renard E, Shah R, Miller M, Kolopp M, Costalat G, Bringer J. Sustained safety and accuracy of central IV glucose sensors connected to implanted insulin pumps and short-term closed-loop trials in diabetic patients. Diabetologia. 2003;46:A47.
188. McShane MJ. Microcapsules as "smart tattoo" glucose sensors: engineering systems with enzymes and glucose-binding sensing elements. In: Geddes CD, Lakowicz JR, eds. Topics in fluorescence spectroscopy. Vol. 11. New York: Springer; 2006, 131-63.
189. Caduff A, Talary MS, Mueller M, Dewarrat F, Klisic J, Donath M, Heinemann L, Stahel WA. Non-invasive glucose monitoring in patients with type 1 diabetes: a multisensor system combining sensors for dielectric and optical characterisation of skin. Biosens Bioelectron. 2009;24(9):2778-84.